LGALS1 and type 2 diabetes mellitus: Here, genetically elevated galectin-1 was associated with higher eGFR (p = 5.7 × 10−3) specifically in individuals with severely insulin-resistant T2D, a group previously known to have an elevated risk of diabetic nephropathy [47].